Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CervoMed Inc shares valued at $18,160 were purchased by ELDER WILLIAM ROBERT on Aug 27 ’24. At $18.16 per share, ELDER WILLIAM ROBERT acquired 1,000 shares. The insider’s holdings grew to 1,267 shares worth approximately $11593.050000000001 following the completion of this transaction.
As published in their initiating research note from Chardan Capital Markets on September 18, 2024, CervoMed Inc [CRVO] has been a Buy and the price target has been revised to $55. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in late July. As of February 15, 2024, Canaccord Genuity has initiated its “Buy” rating for CRVO. Earlier on November 17, 2020, H.C. Wainwright downgraded its rating. Their new recommendation was “a Neutral” for CRVO stock which previously was a “a Buy”.
Analyzing CRVO Stock Performance
During the last five days, there has been a drop of approximately -5.03%. Over the course of the year, CervoMed Inc shares have jumped approximately 19.99%. Shares of the company reached a 52-week high of $26.38 on 03/20/24 and a 52-week low of $7.02 on 01/02/24. A 50-day SMA is recorded $12.83, while a 200-day SMA reached $17.10. Nevertheless, trading volume fell to 0.59 million shares from 0.1 million shares the previous day.
Support And Resistance Levels for CervoMed Inc (CRVO)
According to the 24-hour chart, there is a support level at 8.18, which, if violated, would cause prices to drop to 7.21. In the upper region, resistance lies at 10.21. The next price resistance is at 11.26. RSI (Relative Strength Index) is 34.16 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.70, which suggests the price will decrease in the coming days. Percent R is at 72.29%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Which companies own the most shares of CervoMed Inc (CRVO)?
On March 21, 2018, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $1.25.
